Elanco Animal Health (ELAN) Net Margin (2017 - 2026)
Elanco Animal Health (ELAN) reported Net Margin of 4.16% for Q1 2026, down 146.0% on a YoY basis from 9.04% in Q1 2025, and up 117.23% sequentially from 24.13% in Q4 2025.
Elanco Animal Health (ELAN) Net Margin (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Net Margin data on file, last reported at 4.16% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 146.0% year-over-year to 4.16%; the trailing twelve-month figure through Mar 2026 stood at 4.95% (down 1337.0% YoY), and the FY2025 full-year result was 4.92%, down 1253.0% from the prior year.
- Net Margin grew to 4.16% in Q1 2026, from 24.13% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 35.34% in Q3 2024 to a low of 102.62% in Q3 2023.
- A 5-year average of 6.42% and a median of 0.85% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin slumped 9629 bps in 2023 and surged 13796 bps in 2024, its largest moves.
- Tracing ELAN's Net Margin over 5 years: stood at 5.48% in 2022, then sank by 148 bps to 13.62% in 2023, then jumped by 94 bps to 0.78% in 2024, then slumped by 2976 bps to 24.13% in 2025, then jumped by 117 bps to 4.16% in 2026.
- Business Quant data shows ELAN's Net Margin at 4.16% in Q1 2026, 24.13% in Q4 2025, and 2.99% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -21.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.16% |
| Dec 31, 2025 | -24.13% |
| Sep 30, 2025 | -2.99% |
| Jun 30, 2025 | 0.89% |
| Mar 31, 2025 | 5.62% |
| Dec 31, 2024 | -0.78% |
| Sep 30, 2024 | 35.34% |
| Jun 30, 2024 | -4.22% |
| Mar 31, 2024 | 2.66% |
| Dec 31, 2023 | -13.62% |
| Sep 30, 2023 | -102.62% |
| Jun 30, 2023 | -9.18% |
| Mar 31, 2023 | 8.19% |
| Dec 31, 2022 | -5.48% |
| Sep 30, 2022 | -6.34% |
| Jun 30, 2022 | -0.85% |
| Mar 31, 2022 | 4.16% |
| Dec 31, 2021 | -9.44% |
| Sep 30, 2021 | -9.55% |
| Jun 30, 2021 | -16.12% |